Adenovirus (Ad) vectors can be injected into human ocular tissues without producing adverse events and are therefore a promising means of gene transfer to the retina. However, when administered subretinally, Ad vectors primarily transduce the retinal pigment epithelium (RPE), whereas the majority of mutant gene products that cause photoreceptor (PR) degeneration are expressed exclusively in the PR cells. While it has been shown previously that pseudotyping of Ad can partially overcome the limited PR transduction by Ad5, we found that pseudotyping of Ad is not necessary for transduction of PR cells. We determined that, in the context of Ad, the cytomegalovirus (CMV) promoter is not significantly active in PRs. We compared expression levels from CMV and chicken beta actin (CBA) promoters in neural retina and found that CBA has a 173-fold greater potency than CMV. We also investigated the nature of the Ad-RPE interaction in murine retina and determined that the RGD domain in Ad penton plays a key role in RPE tropism. Deletion of the RGD domain coupled with use of the CBA promoter permitted transgene expression in neural retina approximately 667 times more efficiently than with Ad5 vectors. The use of these vectors in combination with a 4.7 kilobase (kb) rhodopsin promoter enabled transgene expression exclusively in PR cells in vivo.
INTRODUCTION
e use of adenovirus (Ad) vectors has led to substantial success in demonstrating rescue of retinal degeneration in animal models of human disease. 1, 2 In fact, the only two human ocular gene therapy trials to date have selectively used Ad for gene delivery. 3, 4 ese studies strongly suggest that Ad may be an ideal vector for gene transfer to the human retina. Some advantages of Ad over other vector systems include a packaging capacity of 36 kilobase (kb), 5, 6 and ease of scaleable production. Also,episomal persistence and transgene expression extending over years have been demonstrated in non-human primates, 7 and lifetime correction of disease in mice. 8 One of the most common diseases of the retina leading to blindness is retinitis pigmentosa, a ecting approximately 1 in 3,000 individuals worldwide. 9 e most common serotype of Ad used in gene therapy studies is Ad5, which almost exclusively infects the retinal pigment epithelium (RPE) when administered subretinally. [10] [11] [12] Although the RPE provides the essential components for the proper functioning and survival of the adjacent PR cells, the majority of the genes associated with retinitis pigmentosa are expressed exclusively in the PRs. 13 erefore it would initially appear that Ad would not be useful in the treatment of retinitis pigmentosa.
Other than pseudotyped adeno-associated virus (AAV), no previously described gene delivery vectors were able to transduce PRs e ciently in the post-mitotic retina. For example, while lentivirus vectors can transduce 14 and rescue 15 PR degeneration when administered to neonatal mice, they do not transduce the fully developed PRs found in the post-mitotic adult murine retina. [16] [17] [18] Hence, lentivirus vectors have limited use in the treatment of diseases a ecting human PRs which, in contrast to murine PRs, are almost fully developed in utero. 19 Indeed, it has been postulated that the most common time period for intervention in retinal gene therapy experiments in mice (3-7 days a er birth) is likely equivalent to the second trimester of pregnancy in humans. 20 While AAV vectors can overcome this limitation, they have a limited cloning capacity of approximately 5 kb and therefore cannot include the large upstream regulatory elements necessary for regulated expression of transgenes. Regulation of rhodopsin, for example, has been shown to be essential in order to prevent the retinal degeneration that may be induced by as little as 23% overexpression of wild-type rhodopsin in PRs. 21 Because of the limitations in current vector technology, it would be prudent to develop Ad vectors speci cally for retinal gene therapy.
In this study, we examined the utility of Ad5 pseudotyped with Ad17 ber (Ad5/F17), a serotype that has been previously shown to infect neurons in cell culture. 22 We found that Ad5/F17 vectors perform better than Ad5 vectors in their ability to transduce neural retina but do not express high levels of transgene product in the PRs.
All previous studies, including those carried out by us earlier, have apparently made the assumption that, in the context of Ad5 in PR cells, the cytomegalovirus (CMV) promoter is strongly active, and that the absence of reporter gene expression (green uorescent protein (GFP), LacZ etc.) in PRs is an indirect indicator of the failure of Ad5 to transduce PRs. Hence, all of these studies have reached a similar conclusion, i.e., that Ad5 has almost exclusive tropism for the RPE when administered subretinally and that modi cations such as pseudotyping are necessary in order to make Ad5 transduce PR cells. In this study we demonstrate that pseudotyping of Ad is in fact not necessary for achieving PR transduction, because a simple exchange of the transgeneassociated promoter reveals that Ad5 can transduce PR cells to previously unprecedented levels. We expand these observations by probing the structural components of the Ad5 capsid that may be responsible for the substantially higher levels of transduction of RPE at the expense of the PR cells. Given the robust integrinmediated phagocytic activity of the RPE for rod outer segment discs, we postulated that the RGD domain in the Ad penton base may play a signi cant role in Ad5 uptake by the RPE. We corroborated this hypothesis by demonstrating that deletion of the RGD domain in the Ad penton base allows redirecting of Ad5 tropism from its preferential transduction of RPE cells to a now more equitable transduction of both RPE and PRs, and at levels signicantly greater than those achieved by pseudotyping or promoter exchange alone. ese observations further allow for the design of Ad vectors that can express transgenes exclusively in the PR cells.
RESULTS

Ad5 pseudotyped with Ad17 fiber improves transduction of neural retina in vivo
Previous studies have shown that Ad2 pseudotyped with Ad17 ber can infect primary neuronal cells in culture. 22 Because the retina contains a variety of specialized neurons including PRs, we wished to test the hypothesis that Ad5 pseudotyped with Ad17 ber may infect retinal neurons more e ciently than Ad5. In order to construct such a vector, we genetically modi ed the ber gene in Ad5. In brief, we made modi cations such that the resultant vector would express a hybrid ber comprised of the N terminal 10 amino acids unique to Ad5 ber followed by the amino acids FNPVYPY that are common to both Ad5 and Ad17 ber, followed by amino acids 18-366 of Ad17, resulting in a total ber length of 366 amino acids and identical in length to wild-type Ad17 ber (Figure 1a) . e modi ed ber was followed by 62 base pairs of Ad17 sequence derived from the 3 end of Ad17 ber and contained a bovine growth hormone pA signal further downstream in order to ensure appropriate processing of the modi ed transcript. In order to allow quantitation of potentially transduced neurons in vivo, we cloned a CMV-GFP expression cassette in the E1 region of this modi ed virus backbone (Figure 1b) . In order to con rm that the modi ed monomeric Ad5/F17 ber trimerized and was incorporated into mature capsids, we probed the hybrid ber by Western blot analysis using protein prepared from puri ed virions. Our results generally indicated that the monomeric ber is expressed, trimerized, and incorporated into virions and that denaturation by boiling the samples prior to loading allows all of the Ad5/F17 bers to resolve into monomeric bers (Figure 1c ). e molecular weights of the various bers were roughly consistent with the predicted sizes, as determined by amino acid sequence analysis so ware (MacVector). However, we did note that levels of ber from Ad5/F17 were signi cantly lower than those observed for Ad5 (Figure 1c) .
In order to determine whether Ad5/F17 (EGFPNAd5/F17) could transduce retinal neurons, we injected EGFPNAd5/F17 into the subretinal space of adult C57BL/6J mice and measured GFP expression qualitatively by direct uorescence and quantitatively by quantitative real-time polymerase chain reaction of neural retina (i.e., with RPE removed). Qualitatively, it appeared that Ad5/F17 virions transduced the same cell types as the parental Ad5 virus, i.e., we observed primarily RPE-speci c GFP expression and the occasional Müller cell and cells of the inner nuclear layer. However, quantitative real-time polymerase chain reaction revealed that Ad5/F17 virus transduced murine neural retina 24 (±4) times more e ciently than Ad5 did, the greater part of the signal being possibly due to slightly enhanced Müller cell transduction. However, Ad5/F17 did not transduce PRs very e ectively (Figure 1d ).
Expression of GFP in PRs transduced by Ad5
e assumption that the CMV promoter is su cient to determine which cell types are transduced by Ad in the retina has previously led several investigators including ourselves to conclude that PRs are not transduced by Ad5, and that alternative approaches such as pseudotyping are necessary. 23, 24 In order to examine the role of the CMV promoter in the transduction of PRs by Ad, we constructed Ad5 vectors expressing GFP from a chicken beta actin (CBA) promoter/CMV enhancer/rabbit globin intron 25 (Ad5CAGGFP) and from a CMV promoter (Ad5CMVGFP), and injected one or other of these into the subretinal space of adult C57BL/6J mice. An examination of frozen retinal sections (Figure 2 ) 6 days following subretinal injection yielded results in agreement with previous studies, showing that GFP expression from the CMV promoter occurs almost exclusively in the RPE (Figure 2e ). In contrast, in addition to the RPE, cells in the outer nuclear layer are also strongly GFP-positive when the CBA promoter is utilized to regulate transgene expression (Figure 2h) . A close examination of these retinal sections leads to the identi cation of these GFP-positive cells as PR cell bodies and a very large number of GFP-positive inner and outer segments (Figure 2k ), thereby con rming the presence of GFPpositive PRs. Areas in the same retinal section at the border of GFP-positive RPE, presumably the border of the injection site (Figure 2n) , do not reveal any GFP-positive PRs at the exact same exposure. We hence conclude that Ad5 vectors can indeed transduce PR cells, and that the CBA promoter allows robust transgene expression in PRs whereas CMV does not. Robust PR transduction was not limited to the site of injection; a single subretinal injection led to the transduction of approximately 20% of the neural retina and approximately 35% of the RPE (Figure 2h) . Transduction was also observed in the corneal endothelium (data not shown), presumably due to leakage or transport of the vector from the subretinal space into the vitreous. Quantitative real-time polymerase chain reaction of these transduced neural retinas (with RPE removed) indicated that GFP expression from Ad5CAGGFP virus containing a CBA promoter was approximately 173 (±55) times more e cient than expression from the CMV promoter using the same Ad5 backbone.
The role of RGD in the Ad penton base in Ad5-RPE tropism Although PRs are in fact transduced by Ad5, the RPE is still substantially better transduced than the PRs. Beginning with the unproven assumption that the CBA promoter is equally active in both cell types, we sought to investigate the molecular basis for the strong Ad-RPE interaction in order to potentially enhance PR transduction by ameliorating or reducing such interaction. We took into consideration the fact that RPE cells are phagocytic, whose function include binding to and engul ng large amounts of rod outer segments discs shed by the PR cells. 26 ese spent discs are thought to bind the RPE through an RGD-α v β 5 integrin interaction. 27 Coincidentally, Ad5 also binds α v β 5 integrin through an RGD domain in the Ad5 penton base, 28 and this interaction is crucial for Ad5 endocytosis following the initial Ad5 ber knob-coxsackie and adenovirus receptor interaction. 29 We hypothesized that this well-characterized RGD-α v β 5 -integrin interaction could be the cause of the very e cient uptake of Ad5 vectors into the RPE at the expense of the adjacent PRs. In order to investigate this hypothesis, we injected a tetramethylrhodamine isothiocyanate-labeled RGD-containing peptide into the subretinal space of adult C57BL/6J mice. Mouse eyes harvested 90 minutes later indicated that the RGD-containing peptide bound primarily to the RPE and the blood vessels present in the inner retina (Figure 3a) but not to the PR cells, a pattern similar in part to Ad5 transduction of the retina. In contrast, a tetramethylrhodamine isothiocyanate-labeled peptide containing RGE did not signi cantly bind the RPE but did bind the blood vessels in the inner retina, albeit at a lower e ciency relative to the RGDcontaining peptide (Figure 3b) . If indeed RGD were a critical player in the Ad-RPE interaction, one would have expected to transduce the RPE as well as the blood vessels with RGD-containing Ad5 viruses expressing GFP, from a promoter active in both these tissues. However, in this study, high levels of Ad5 transduction were observed only in the RPE and PRs (Figure 2) . is could be because: (i) the spaces between the neurons in the retina do not allow easy access of Ad to the blood vessels in the inner retina following subretinal administration, or (ii) insu cient virus is available to reach the inner blood vessels because the potentially strong RGD-RPE interaction functions as a sink for Ad vectors in the subretinal space. Nonetheless, these data are consistent with the hypothesis that RGD in the Ad5 penton base may play an important role in the substantial a nity of Ad5 for RPE.
If this hypothesis is correct, deletion of the RGD from the Ad5 vector should reduce the Ad-RPE interaction and hence potentially make available more of the Ad for uptake by adjacent cells such as the PRs. In order to test this hypothesis, we rescued Ad5 vector expressing GFP from a CBA promoter on an Ad5 backbone with an RGD deletion in Ad penton base (Ad5CAGGFP∆RGD).
ese constructs were injected into the subretinal space of adult C57BL/6J mice, and frozen retinal sections were examined 6 days later. We noticed key di erences between Ad5CAGGFP-and Ad5CAGGFP∆RGD-injected mouse retina. First, the region of the neural retina that was transduced was substantially larger when Ad5CAGGFP∆RGD was used, with as much as 50% of the neural retina being transduced by a single injection (Figure 4b and c) , and the outer nuclear layer was signi cantly GFP-positive within this transduced area (Figure 4e) . Second, a very large number of the PR cell bodies were GFP-positive in the area of subretinal injection (Figure 4h) , as well as blood vessels (arrowheads, Figure 4h ) and select ganglion cells (Figure 4h) . Longer exposures of these sections (data not shown) indicated that cells in the inner layers of the retina were also signi cantly transduced. Indeed, a "blanket" of GFP-positive inner segments (Figure 4h , inset) could be easily discerned. In contrast, similar exposures of relatively untransduced areas from the same retina did not reveal any GFP-positive PRs (Figure 4k) . Quantitation of these data by real-time polymerase chain reaction indicated that Ad5CAGGFP∆RGD drove GFP expression in neural retina 667 (±19) times higher than Ad5 with a CMV promoter and 4 (±1.24) times higher than Ad5CAGGFP. Whether the level of transgene expression achieved in PR cells in these studies surpasses that which can be achieved by a single administration of AAV remains to be determined.
PR-specific transgene expression
Having demonstrated improved transgene expression in neural retina and speci cally in PRs using Ad vectors with deletion of RGD penton base, we sought to examine whether such vectors could be utilized for expressing transgenes in a PR-speci c manner. As discussed earlier, the control of transgene expression is critically important in retinal gene therapy and, in theory, the 36 kb cloning capacity of helper-dependent Ad vectors can be utilized for delivering the entire human rhodopsin gene or other genes involved in retinal regeneration including introns and large upstream regulatory elements. Appropriately regulated PRspeci c transgene expression would thus provide a further level of safety in human gene therapy protocols. As a step towards that goal, we generated an Ad vector (Ad5RhoGFP∆RGD) expressing GFP regulated by a 4.7 kb murine opsin promoter. Frozen retinal sections prepared from mice 3 weeks a er subretinal injection revealed GFP expression in the area of the injection (Figure 5b) . GFP expression was exclusively localized to the outer nuclear layer that contains the PR cell bodies (Figure 5e and f) and the inner and outer segments of the PR cells. Individual GFPpositive outer segments of PR cells could be easily discerned in these sections (Figure 5e ). Signi cantly, there was absolutely no transgene expression in any other retinal cell type examined, including the RPE cell which is the one that is most e ciently transduced by all viral vector groups tested to date.
DISCUSSION
e use of ad vectors has met with substantial success in the only two human ocular gene therapy trials to date. In both these trials, a dose escalation study revealed no signi cant adverse events at the highest doses tested- e abandonment of Ad in animal ocular gene therapy has come about, in part, as a result of the substantial immune response observed in animals following administration of Ad into ocular tissues. 31, 32 However, in some murine ocular gene transfer studies it has been demonstrated that long-term transgene expression is indeed possible, exceeding 6 months, the longest time period of examination. 24, 33 Given the promising data from human ocular gene therapy studies using Ad, its exclusion in favor of alternative vectors may have been premature, especially given some of the advantages it has over other vector systems.
In this study we have examined the current drawbacks of Ad vector technology in the treatment of diseases involving PR degeneration. As is the case with lentivirus, earlier generations of Ad5 vectors can transduce PRs only during the early phase of retinal development. 34 Hence, while such vectors can be used for rescuing degenerating PRs in murine neonates, 1,2 they do not have much potential for application in similar diseases in humans. is is probably because of key di erences between mice and humans in the timing of postnatal PR development. is limitation in tropism is not valid for in utero gene transfer but technical and ethical hurdles are likely to slow such applications.
In order to address these de ciencies, we rst examined the potential extent of PR transduction by Ad5 vectors pseudotyped with Ad17 ber, a pseudotype known to infect post-mitotic neuronal cells in culture. 22 Previous e orts to redirect Ad tropism from RPE to PRs include similar approaches, e.g., Ad5 pseudotyped with Ad37 (Ad5/f37) 23 or Ad35 (Ad5/f35) 24 ber. We have previously shown 35 that Ad5/f37 can be redirected from binding its native receptor to binding sialic acid, an amino carbohydrate abundantly present in the retina. In those former studies, Ad vectors expressing GFP from a CMV promoter were utilized to demonstrate PR transduction. GFP expression was directly observable in PRs when the Ad5/f37 vector was used, 23 whereas, in the case of the Ad5/f35 vector, indirect and signi cantly more sensitive methods of detecting GFP, i.e., antibodies, were found to be necessary. 24 Although we did nd an improvement in transduction of neural retina with Ad5/f17 vectors, it appeared to be on account of a slightly increased transduction of Müller cells and other cells in the inner nuclear layers rather than the PRs.
Although the CMV promoter has been shown to be active in PRs when CMV-regulated expression cassettes are delivered to PRs by alternative vectors such as AAV, 36 it is surprising that there is almost no transgene expression in PRs in the context of Ad. One possible explanation for this observation is that Ad may generate a greater immune response than AAV does in murine ocular tissues, and this may initiate a cascade of events that rapidly shuts o , at least partially, viral promoters such as CMV. For example, interferon-γ has been shown to bind and shut down expression from the CMV promoter as part of the natural host immune response. 37 We have tested PR expression from CMV promoters in the context of Ad with both sense and antisense orientations with respect to the E1 enhancer and seen similar results (data not shown). is implies that the location of the CMV promoter and its proximity to Ad E1 enhancers may not be relevant. Surprisingly, we were able to demonstrate substantial transduction of PRs by use of the CBA promoter, from which it appears that the obstacle to PR transduction is at least partly at the level of transcription and not exclusively at the infection stage as had been documented previously.
Previous studies have examined the role that RGD in the Ad penton base plays in mediating entry into non-ocular cells in vivo. In those studies it was determined that RGD deletions do not substantially change the levels of Ad uptake by, for example, the liver following intravenous injection. 38 A variety of studies have reported enhanced Ad uptake into cells, o en neoplastic cells that express high levels of integrin, by incorporation of RGD in the H1 loop of the ber knob. 39 Our study is hence atypical, in that we achieved enhanced targeting of the cell of interest by reducing rather than increasing the RGD-integrin interaction. While we did not demonstrate conclusively that the RGD-RPE interaction is exclusively responsible for the e cient uptake of Ad at the expense of the PRs, we did nonetheless nd that deletions in RGD allowed substantial improvements in PR transduction. Further studies are necessary in order to characterize in detail the interactions between RPE and Ad-uptake. Finally, we demonstrated that a 4.7 kb murine opsin promoter may be utilized to drive GFP expression exclusively in the PR cells. To the best of our knowledge, this is the largest PR-speci c promoter delivered ectopically to PR cells thus far. While the RGD deletion in Ad penton base (Ad5∆RGD) allowed for improved PR transduction, the use of the 4.7 kb opsin promoter on such viral backbones allowed expression exclusively in PR cells. We did not examine whether Ad5 vectors expressing transgenes regulated from this same promoter are also capable of PR-speci c transgene expression. However, our data support the idea that transgene levels from Ad5 vectors are likely to be lower than from Ad5∆RGD vectors in PRs, because of an a priori di erence in rates of PR transduction.
With a greater understanding of Ad tropism in ocular tissues, the vectors described in this study can be applied in gene therapy studies of a variety of ocular diseases involving the degeneration of the retina. Cumulatively, the data and vectors described in this study should be useful for the rescue of PRs in animal models of retinal degeneration and patients with retinitis pigmentosa and allied retinal disorders.
MATERIALS AND METHODS
Construction of plasmids. pAd5/F17 and pShEGFPN were generated essentially as previously described for pAd5/F37. 35 Wild-type Ad17, strain Ch.22, was obtained from the American Type Tissue Culture Collection. pShCAG GFP was constructed by cloning an SpeI/HindIII fragment of pCAGGFP (a generous gi from C. Cepko and T. Matsuda) into XbaI/HindIII-digested pShuttle. 40 pAdAdEasy1∆RGD was constructed by cloning an FseI fragment from AdHM4∆RGD (generously provided by A. Lieber) into FseIdigested pAdEasy1. 40 e 4.7 kb murine opsin promoter was cloned as a BamHI fragment from pSB6.25 (generously provided by W. Baehr) and used for generating a GFP-expressing shuttle as earlier described for pSh CAGGFP. Further cloning details are available upon request.
Production of adenoviruses.
Viruses were produced as previously described. 12, 40 In brief, adenoviruses were produced by recombination between the respective shuttle plasmid and modi ed Ad backbone in BJ5183 cells. Recombined plasmids were digested with PacI and transfected into the human embryonic retinoblast (911) cell line, 41 and the resultant viruses were puri ed using the Adenopure kit (Puresyn).
Western blot analysis of fiber. 3.2 × 10
10 virus particles were resuspended in 50 mmol/l Tris-HCl, pH 8.0/150 mmol/l NaCl/0.1% Sodium dodecyl sulfate/1% Triton X-100 containing leupeptin (10 µg/ml), aprotinin (10 µg/ml), and phenylmethanesulphonyl uoride (0.1 mmol/l). Half of the lysate was pre-incubated at 100 C. ese were then loaded on a 12% denaturing gel (BMA, Rockland, ME) and probed for ber using the monoclonal antibody Ab-4 (Clone 4D2; NeoMarkers), followed by a horseradish peroxidase-conjugated goat anti-mouse antibody (Jackson ImmunoResearch).
Subretinal injections. C57Bl/6J mice were bred and maintained in a 12-hour light-dark cycle and cared for in accordance with federal, state and local regulations. e use of animals in this work was in accordance with the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. Mice were anesthetized by intraperitoneal injection of xylazine (10 mg/ml)/ketamine (1 mg/ml). Subretinal injections were performed using the transcleral approach with a 32G needle attached to a 5 μl glass syringe (Hamilton). 3 × 10 9 virus particles were injected into C57Bl/6J mice. 17.5 nmol of either the tetramethylrhodamine isothiocyanate-labeled 6-amino acid GRGDSP peptide or the GRGESP peptide was injected into the sub-retinal space of C57Bl6/J mice. Eyes were harvested 90 minutes post-injection and imaged as described in the following text.
Quantitative RT-PCR. Retinas (n = 4 per construct) were dissected and processed for total RNA using RNA STAT-60, according to the manufacturer's instructions (Tel-Test). DNAse-treated RNA was reversetranscribed using oligod(T) 16 and TaqMan (Applied Biosystems) reverse transcription kit according to the manufacturer's instructions. Single PCRs were performed on cDNA using TaqMan Universal PCR Master Mix (Applied Biosystems) and analyzed using the ABI PRISM 7900HT Sequence Detection System. GFP messenger RNA was detected using the primer/probe combination EGFP-F 5 -GAGCGCACCATCTTCTT CAAG-3 , EGFP-R 5 -TGTCGCCCTCGAACTTCAC-3 and EGFP-M1 ACGACGGCAACTACA, an assay custom-designed by Applied Biosystems. Normalization was performed using a TaqMan endogenous mouse β-actin control primer/probe combination (Applied Biosystems part no. 4352663). All probes contained the covalently-linked reporter FAM dye at their 5 ends and a TAMRA quencher dye at their 3 ends.
Image analysis. Six days a er injection (except for Ad5RhoGFP∆RGD which was analyzed 3 weeks a er injection), mice were sacri ced by CO 2 inhalation. Eyes were harvested and xed with 4% paraformaldehyde prior to sectioning. Tissues were visualized with a Nikon Eclipse TS100 or Olympus IX51 microscope with a 120 W metal halide lamp and a GFP lter (excitation/emission maxima 474 nm/509 nm). Images were captured using Image Pro or CoolSnap so ware.
